FOXL2: a central transcription factor of the ovary

被引:119
作者
Georges, Adrien [1 ,2 ]
Auguste, Aurelie [1 ,2 ]
Bessiere, Laurianne [1 ,2 ]
Vanet, Anne [1 ,2 ]
Todeschini, Anne-Laure [1 ,2 ]
Veitia, Reiner A. [1 ,2 ]
机构
[1] Inst Jacques Monod, CNRS, UMR 7592, F-75013 Paris, France
[2] Univ Paris 07, Univ Paris Diderot, Paris, France
关键词
cancer; oestrogen receptors; ovary; ovarian function; FOXL2; GRANULOSA-CELL TUMORS; PRIMARY FOLLICLE TRANSITION; ANTI-MULLERIAN HORMONE; BETA-SUBUNIT TRANSCRIPTION; MAMMALIAN OVARY; SEX-REVERSAL; FORKHEAD TRANSCRIPTION; GENE-EXPRESSION; MOUSE OVARY; IN-VITRO;
D O I
10.1530/JME-13-0159
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Forkhead box L2 (FOXL2) is a gene encoding a forkhead transcription factor preferentially expressed in the ovary, the eyelids and the pituitary gland. Its germline mutations are responsible for the blepharophimosis ptosis epicanthus inversus syndrome, which includes eyelid and mild craniofacial defects associated with primary ovarian insufficiency. Recent studies have shown the involvement of FOXL2 in virtually all stages of ovarian development and function, as well as in granulosa cell (GC)-related pathologies. A central role of FOXL2 is the lifetime maintenance of GC identity through the repression of testis-specific genes. Recently, a highly recurrent somatic FOXL2 mutation leading to the p. C134W subtitution has been linked to the development of GC tumours in the adult, which account for up to 5% of ovarian malignancies. In this review, we summarise data on FOXL2 modulators, targets, partners and post-translational modifications. Despite the progresses made thus far, a better understanding of the impact of FOXL2 mutations and of the molecular aspects of its function is required to rationalise its implication in various pathophysiological processes.
引用
收藏
页码:R17 / R33
页数:17
相关论文
共 126 条
[1]   Molecular Mechanisms Underlying the Activation of Mammalian Primordial Follicles [J].
Adhikari, Deepak ;
Liu, Kui .
ENDOCRINE REVIEWS, 2009, 30 (05) :438-464
[2]   Conditional deletion of the retinoblastoma (Rb) gene in ovarian granulosa cells leads to premature ovarian failure [J].
Andreu-Vieyra, Claudia ;
Chen, Ruihong ;
Matzuk, Martin M. .
MOLECULAR ENDOCRINOLOGY, 2008, 22 (09) :2141-2161
[3]  
[Anonymous], 2003, WHO CLASSIFICATION T
[4]   Loss of R-Spondin1 and Foxl2 Amplifies Female-to-Male Sex Reversal in XX Mice [J].
Auguste, A. ;
Chassot, A. -A. ;
Gregoire, E. P. ;
Renault, L. ;
Pannetier, M. ;
Treier, M. ;
Pailhoux, E. ;
Chaboissier, M. -C. .
SEXUAL DEVELOPMENT, 2011, 5 (06) :304-317
[5]   ANTI-MULLERIAN HORMONE AND ANTI-MULLERIAN HORMONE TYPE-II RECEPTOR MESSENGER-RIBONUCLEIC-ACID EXPRESSION IN RAT OVARIES DURING POSTNATAL-DEVELOPMENT, THE ESTROUS-CYCLE, AND GONADOTROPIN-INDUCED FOLLICLE GROWTH [J].
BAARENDS, WM ;
UILENBROEK, JTJ ;
KRAMER, P ;
HOOGERBRUGGE, JW ;
VANLEEUWEN, ECM ;
THEMMEN, APN ;
GROOTEGOED, JA .
ENDOCRINOLOGY, 1995, 136 (11) :4951-4962
[6]   Steroidogenic factor-1 contributes to the cyclic-adenosine monophosphate down-regulation of human SRY gene expression [J].
Barbara, PD ;
Méjean, C ;
Moniot, B ;
Malclès, MH ;
Berta, P ;
Boizet-Bonhoure, B .
BIOLOGY OF REPRODUCTION, 2001, 64 (03) :775-783
[7]   Homozygous inactivation of Sox9 causes complete XY sex reversal in mice [J].
Barrionuevo, F ;
Bagheri-Fam, S ;
Klattig, J ;
Kist, R ;
Taketo, MM ;
Englert, C ;
Scherer, G .
BIOLOGY OF REPRODUCTION, 2006, 74 (01) :195-201
[8]   Potential targets of FOXL2, a transcription factor involved in craniofacial and follicular development, identified by transcriptomics [J].
Batista, Frank ;
Vaiman, Daniel ;
Dausset, Jean ;
Fellous, Marc ;
Veitia, Reiner A. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (09) :3330-3335
[9]  
BEAMER WG, 1985, CANCER RES, V45, P5575
[10]   Adult ovarian granulosa cell tumor transcriptomics: prevalence of FOXL2 target genes misregulation gives insights into the pathogenic mechanism of the p.Cys134Trp somatic mutation [J].
Benayoun, B. A. ;
Anttonen, M. ;
L'Hote, D. ;
Bailly-Bechet, M. ;
Andersson, N. ;
Heikinheimo, M. ;
Veitia, R. A. .
ONCOGENE, 2013, 32 (22) :2739-2746